Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine Adjuvant Therapy for Chronic Visceral Pain Comorbid with Depression
NCT04847245Phase 2Unknown
- Sponsor
- Peking University
- Start
- May 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of esketamine in Chronic visceral pain, major depressive disorder (MDD), sponsored by Peking University. Status: unknown.
02
Drugs
esketamine
03
Conditions
Chronic visceral painmajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04847245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04847245.